--------------------------
OMB Approval
--------------------------
UNITED STATES OMB Number: 3235-0060
SECURITIES AND EXCHANGE COMMISSION Expires: April 30, 2009
Washington, D.C. 20549 Estimated average burden
hours per response. .38.0
--------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 5, 2007
-------------------------------
POSSIS MEDICAL, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Minnesota 0-944 41-0783184
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
9055 Evergreen Boulevard NW, Minneapolis, MN 55433-8003
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 763-780-4555
------------------------------
Not Applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 - Regulation FD Disclosure
On April 5, 2007, Possis Medical, Inc., announced that it is participating in
the SunTrust Robinson Humphrey 36th Annual Institutional Conference to be held
April 10 and 11 at the Ritz-Carlton Buckhead in Atlanta, Georgia. Robert
Dutcher, chairman, president and CEO, is scheduled to present a company overview
and discuss Possis' pioneering medical technologies to conference attendees at
3:15 p.m. ET on April 10.
Item 9.01 Financial Statements and Exhibits
[c] Exhibits
99.1 Press Release, dated April 5, 2007, issued by Possis Medical, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Possis Medical, Inc.
- --------------------
(Registrant)
Date: April 5, 2007
-------------
By: /s/ Jules L. Fisher
--------------------------------------------------
Jules L. Fisher
Vice President, Finance and Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
- ----------- -----------
99.1 Press Release, dated April 5, 2007, issued by Possis Medical, Inc.